BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19093957)

  • 1. Human immunodeficiency virus-1 acquisition in genital mucosa: Langerhans cells as key-players.
    de Jong MA; Geijtenbeek TB
    J Intern Med; 2009 Jan; 265(1):18-28. PubMed ID: 19093957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission.
    de Witte L; Nabatov A; Geijtenbeek TB
    Trends Mol Med; 2008 Jan; 14(1):12-9. PubMed ID: 18055263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function.
    de Jong MA; de Witte L; Taylor ME; Geijtenbeek TB
    J Immunol; 2010 Aug; 185(3):1633-41. PubMed ID: 20592277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells.
    de Witte L; Nabatov A; Pion M; Fluitsma D; de Jong MA; de Gruijl T; Piguet V; van Kooyk Y; Geijtenbeek TB
    Nat Med; 2007 Mar; 13(3):367-71. PubMed ID: 17334373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Langerhans cells in the sexual transmission of HIV.
    Kawamura T; Kurtz SE; Blauvelt A; Shimada S
    J Dermatol Sci; 2005 Dec; 40(3):147-55. PubMed ID: 16226431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutz-3-derived Langerhans cells are a model to study HIV-1 transmission and potential inhibitors.
    de Jong MA; de Witte L; Santegoets SJ; Fluitsma D; Taylor ME; de Gruijl TD; Geijtenbeek TB
    J Leukoc Biol; 2010 Apr; 87(4):637-43. PubMed ID: 20042470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Langerhans cells in innate defense against pathogens.
    de Jong MA; Geijtenbeek TB
    Trends Immunol; 2010 Dec; 31(12):452-9. PubMed ID: 21030306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission.
    Kaul R; Pettengell C; Sheth PM; Sunderji S; Biringer A; MacDonald K; Walmsley S; Rebbapragada A
    J Reprod Immunol; 2008 Jan; 77(1):32-40. PubMed ID: 17395270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Langerhans cells and viral immunity.
    Cunningham AL; Carbone F; Geijtenbeek TB
    Eur J Immunol; 2008 Sep; 38(9):2377-85. PubMed ID: 18792031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 transmission in the male genital tract.
    Ganor Y; Bomsel M
    Am J Reprod Immunol; 2011 Mar; 65(3):284-91. PubMed ID: 21114566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syndecan 4 Upregulation on Activated Langerhans Cells Counteracts Langerin Restriction to Facilitate Hepatitis C Virus Transmission.
    Nijmeijer BM; Eder J; Langedijk CJM; Kaptein TM; Meeussen S; Zimmermann P; Ribeiro CMS; Geijtenbeek TBH
    Front Immunol; 2020; 11():503. PubMed ID: 32292405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 exposure and immune activation enhance sexual transmission of Hepatitis C virus by primary Langerhans cells.
    Nijmeijer BM; Sarrami-Forooshani R; Steba GS; Schreurs RR; Koekkoek SM; Molenkamp R; Schinkel J; Reiss P; Siegenbeek van Heukelom ML; van der Valk M; Ribeiro CM; Geijtenbeek TB
    J Int AIDS Soc; 2019 Mar; 22(3):e25268. PubMed ID: 30932366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of immature primary Langerhans cells from human epidermal skin.
    de Jong MA; de Witte L; Geijtenbeek TB
    Methods Mol Biol; 2010; 595():55-65. PubMed ID: 19941105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 infection of Langerhans cells in a reconstructed vaginal mucosa.
    Sivard P; Berlier W; Picard B; Sabido O; Genin C; Misery L
    J Infect Dis; 2004 Jul; 190(2):227-35. PubMed ID: 15216455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of two temporal phases of HIV-1 transfer from primary Langerhans cells to T cells: the role of langerin.
    Nasr N; Lai J; Botting RA; Mercier SK; Harman AN; Kim M; Turville S; Center RJ; Domagala T; Gorry PR; Olbourne N; Cunningham AL
    J Immunol; 2014 Sep; 193(5):2554-64. PubMed ID: 25070850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Langerhans cells and HIV infection.
    Zambruno G; Giannetti A; Bertazzoni U; Girolomoni G
    Immunol Today; 1995 Nov; 16(11):520-4. PubMed ID: 7495488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal and mucosal dendritic cells and HIV1 infection.
    Schmitt D; Dezutter-Dambuyant C
    Pathol Res Pract; 1994 Oct; 190(9-10):955-9. PubMed ID: 7899146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral immune responses by human langerhans cells and dendritic cells in HIV-1 infection.
    van den Berg LM; Geijtenbeek TB
    Adv Exp Med Biol; 2013; 762():45-70. PubMed ID: 22975871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells.
    Merad M; Ginhoux F; Collin M
    Nat Rev Immunol; 2008 Dec; 8(12):935-47. PubMed ID: 19029989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of the role of oral epithelial cells and Langerhans cells as possible HIV viral reservoirs.
    Boy SC; van Heerden MB; Wolfaardt M; Cockeran R; Gema E; van Heerden WF
    J Oral Pathol Med; 2009 Jan; 38(1):114-9. PubMed ID: 19192056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.